Treatment of GIT disorders by optimising the normal microbiota: A review

Authors

  • Asif Rasheed Professor, HOD of Pharmacology, Deccan School of Pharmacy,
  • Sobiya Fatima Deccan School of Pharmacy (affiliated to OU)
  • Ammaarah Fatima Ahmed Professor, HOD of Pharmacology, Deccan School of Pharmacy

DOI:

https://doi.org/10.7439/ijpr.v9i2.5087

Keywords:

dysbiosis, symbiosis, pathogens, heterogeneity

Abstract

The human gastrointestinal (GI) tract harbours a complex and dynamic population of microorganisms, the gut microbiota, which exert a marked influence on the host during homeostasis and disease. Multiple factors contribute to the establishment of the human gut microbiota during formative years. Diet is considered as one of the main point in shaping the gut microbiota across the life time. Intestinal bacteria play a crucial role in maintaining immune and metabolic homeostasis and protecting against pathogens. Altered gut bacterial composition has been associated with the pathogenesis of many provocative diseases and infections. The interpretation of these studies relies on a better understanding of inter-individual variations, heterogeneity of bacterial communities along and across the GI tract, functional redundancy and the need to distinguish cause from effect in states of dysbiosis. This review summarises our current understanding of the development and composition of the human GI microbiota, and its impact on gut integrity , underlying the need for mechanistic studies focusing on host microbe interactions.

Downloads

Download data is not yet available.

Downloads

Published

2019-06-06

Issue

Section

Review Article

How to Cite

1.
Rasheed A, Fatima S, Ahmed AF. Treatment of GIT disorders by optimising the normal microbiota: A review. Int J of Pharmc Res [Internet]. 2019 Jun. 6 [cited 2025 Mar. 14];9(2):e5087. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/5087